These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1099 related articles for article (PubMed ID: 36620648)

  • 1. Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
    Fang C; Chen Z; Zhang J; Jin X; Yang M
    Front Cardiovasc Med; 2022; 9():1050785. PubMed ID: 36620648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTH Predicts the in-Hospital MACE After Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction.
    Wu ZF; Su WT; Chen S; Xu BD; Zong GJ; Fang CM; Huang Z; Hu XJ; Wu GY; Ma XL
    Ther Clin Risk Manag; 2023; 19():699-712. PubMed ID: 37641783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-hospital major adverse cardiovascular events after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: a retrospective study under the China chest pain center (standard center) treatment system.
    Huang L; Zhang J; Huang Q; Cui R; Chen J
    BMC Cardiovasc Disord; 2023 Apr; 23(1):198. PubMed ID: 37069503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the predictive value of the modified CADILLAC, GRACE and TIMI risk scores for the risk of short-term death in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention].
    Ji C; Song F; Huang X; Qu X; Qiu N; Zhu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Mar; 35(3):299-304. PubMed ID: 36916344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and validation of nomogram model for predicting major adverse cardiac events in patients with acute ST-segment elevation myocardial infarction based on glycosylated hemoglobin A1c to apolipoprotein A1 ratio: An observational study.
    Zhang KP; Guo QC; Mu N; Liu CH
    Medicine (Baltimore); 2024 Jun; 103(24):e38563. PubMed ID: 38875361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nomogram risk prediction model for no-reflow after primary percutaneous coronary intervention based on rapidly accessible patient data among patients with ST-segment elevation myocardial infarction and its relationship with prognosis.
    Liu Y; Ye T; Chen K; Wu G; Xia Y; Wang X; Zong G
    Front Cardiovasc Med; 2022; 9():966299. PubMed ID: 36003914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Predictive Model for Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention in Elderly Patients with ST-Segment Elevation Myocardial Infarction.
    Qiu H; Zhu Y; Shen G; Wang Z; Li W
    Clin Interv Aging; 2023; 18():453-465. PubMed ID: 36987461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of triglyceride glucose index combined with neutrophil-to-lymphocyte ratio for major adverse cardiac events after PCI for acute ST-segment elevation myocardial infarction.
    Wang L; Wang Y; Wang W; Wang Z
    Sci Rep; 2024 Jun; 14(1):12634. PubMed ID: 38824158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of Nomogram for the Prediction of Malignant Ventricular Arrhythmia Including Circulating Inflammatory Cells in Patients with Acute ST-Segment Elevation Myocardial Infarction.
    Wang L; Yang L; Li T; Geng S
    J Inflamm Res; 2023; 16():3185-3196. PubMed ID: 37529768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and validation of a risk model for prediction of in-hospital mortality in patients with acute ST-elevation myocardial infarction after primary PCI.
    Gao N; Qi X; Dang Y; Li Y; Wang G; Liu X; Zhu N; Fu J
    BMC Cardiovasc Disord; 2020 Dec; 20(1):513. PubMed ID: 33297955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and validation of a clinical nomogram model based on serum YKL-40 to predict major adverse cardiovascular events during hospitalization in patients with acute ST-segment elevation myocardial infarction.
    Fang C; Li J; Wang W; Wang Y; Chen Z; Zhang J
    Front Med (Lausanne); 2023; 10():1158005. PubMed ID: 37283624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a nomogram model for predicting in-hospital mortality risk in patients with acute ST-elevation myocardial infarction and acute heart failure post-PCI.
    Yu F; Xu Y; Peng J
    Scand Cardiovasc J; 2024 Dec; 58(1):2387001. PubMed ID: 39092557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a prognostic model for predicting post-discharge mortality risk in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI).
    Zhang L; Liu Z; Zhu Y; Wu M; Huang H; Yang W; Peng K; Zeng J
    J Cardiothorac Surg; 2024 Mar; 19(1):163. PubMed ID: 38555468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and validation of a predictive model for major adverse cardiovascular events in the long term after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
    Yang Y; Yin X; Zhang Y; Ren L
    Coron Artery Dis; 2024 Sep; 35(6):471-480. PubMed ID: 38656258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive values of bilirubin for in-hospital adverse events in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
    Ying C; Liu CF; Guo DQ; Du ZR; Wei YJ
    Clinics (Sao Paulo); 2023; 78():100306. PubMed ID: 37949037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value of the nomogram model of clinical risk factors for ischemia-reperfusion injury after primary percutaneous coronary intervention.
    Wang Z; Peng J
    Sci Rep; 2023 Mar; 13(1):5084. PubMed ID: 36977721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved heart function and cardiac remodelling following sacubitril/valsartan in acute coronary syndrome with HF.
    Liu H; Su Y; Shen J; Jiao Y; Li Y; Liu B; Hou X; Jin Q; Chen Y; Sun Z; Xi Q; Feng B; Fu Z
    ESC Heart Fail; 2024 Apr; 11(2):937-949. PubMed ID: 38224955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting long-term prognosis after percutaneous coronary intervention in patients with new onset ST-elevation myocardial infarction: development and external validation of a nomogram model.
    Ye Z; Xu Y; Tang L; Wu M; Wu B; Zhu T; Wang J
    Cardiovasc Diabetol; 2023 Apr; 22(1):87. PubMed ID: 37055777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of carotid intima-media thickness and plasma homocysteine in acute ST-segment elevation myocardial infarction.
    Ou Q; Zhang J; Wen X; Yang L; Tao L
    Cardiovasc Diagn Ther; 2023 Dec; 13(6):917-928. PubMed ID: 38162099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of platelet/lymphocyte ratio and CAMI-STEMI score for major adverse cardiac events in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: A prospective observational study.
    Wang Y; Peng Z
    Medicine (Baltimore); 2021 Aug; 100(33):e26942. PubMed ID: 34414954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.